8-K: Marpai CEO Lamendola Takes On President Role
Executive Change
Marpai, Inc. announced that CEO Damien Lamendola will assume the role of President following Dallas Scrip's resignation, effective January 30, 2026.
Summary
- Dallas Scrip resigned from his position as President of Marpai, Inc., effective January 30, 2026.
- His resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices.
- Damien Lamendola, the current Chief Executive Officer and a member of the Board of Directors, was appointed to serve as President of the Company, effective January 30, 2026.
- Mr. Lamendola has served as the Company's Chief Executive Officer since November 2023 and joined the Board on April 1, 2021.
- He brings extensive experience, including founding Continental Benefits, LLC in 2013 and serving as President of HillCour Holding Corporation since March 2002.
- Mr. Lamendola and an entity he controls, along with an immediate family member, were involved in several securities purchase agreements with the Company in 2025, which were previously disclosed.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to the smooth transition of leadership, with the outgoing President's resignation not attributed to disagreements, and the incoming President being the current CEO with extensive experience, suggesting stability and continuity in executive management.
Positives
- The resignation of Dallas Scrip was explicitly stated not to be a result of any disagreement with the company's operations, policies, or practices, suggesting a smooth and amicable transition.
- Damien Lamendola, the current CEO and an experienced Board member, is taking on the President role, indicating leadership continuity and a potential streamlining of executive functions.
- Mr. Lamendola brings extensive industry experience, including founding Continental Benefits, LLC and long-term leadership roles at HillCour Holding Corporation, which could benefit Marpai's strategic direction.
Future Outlook
NA
Management Comments
- Dallas Scrip's resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.
Industry Context
This executive change reflects an internal leadership transition within Marpai, Inc., with the CEO consolidating roles. Such moves can occur for various reasons, including streamlining management structures or leveraging existing leadership's experience. Without further context on industry trends or competitor actions, it's difficult to assess broader implications, but it suggests a focus on internal stability and continuity.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President | Dallas Scrip | Damien Lamendola | 2026-01-30 | Dallas Scrip resigned; Damien Lamendola, current CEO, appointed to consolidate leadership. |
Related Party Transactions
- Damien Lamendola and HillCour Investment Fund, LLC (an entity controlled by Mr. Lamendola) were parties to several securities purchase agreements with the Company in July and September 2025.
- An immediate family member of Mr. Lamendola was a party to a securities purchase agreement with the Company in November 2025.
- These transactions were previously disclosed in earlier Form 8-K filings.
Stakeholder Impact
- Shareholders may view the consolidation of CEO and President roles under an experienced leader as a positive for stability and streamlined decision-making. The disclosure of related-party securities purchases involving the CEO and his affiliates might warrant closer scrutiny by some investors, though they were previously disclosed.
- Employees are likely to experience continuity and reduced uncertainty due to a stable leadership transition with an internal appointment.
- Customers and suppliers are unlikely to see immediate direct impact from this executive change, as the CEO remains in place and takes on an additional role.
Key Dates
| Date | Description |
|---|---|
| 2002-03-01 | Damien Lamendola became President of HillCour Holding Corporation. |
| 2013-01-01 | Damien Lamendola founded Continental Benefits, LLC. |
| 2017-01-01 | Damien Lamendola became a Board Member of HillCour Holding Corporation and WellDyneRx, LLC, and Manager of HillCour Investment Fund, LLC. |
| 2019-01-01 | Damien Lamendola ceased being Chief Executive Officer of Continental Benefits, LLC. |
| 2021-04-01 | Damien Lamendola joined Marpai, Inc.'s Board of Directors. |
| 2023-11-01 | Damien Lamendola became Chief Executive Officer of Marpai, Inc. |
| 2025-07-17 | Date of a securities purchase agreement involving Mr. Lamendola or his controlled entity. |
| 2025-07-29 | Date of a securities purchase agreement involving Mr. Lamendola or his controlled entity. |
| 2025-09-10 | Date of a securities purchase agreement involving Mr. Lamendola or his controlled entity. |
| 2025-09-30 | Date of a securities purchase agreement involving Mr. Lamendola or his controlled entity. |
| 2025-11-07 | Date of a securities purchase agreement involving an immediate family member of Mr. Lamendola. |
| 2026-01-16 | Dallas Scrip resigned from his position as President of Marpai, Inc. |
| 2026-01-23 | Marpai, Inc. Board of Directors appointed Damien Lamendola as President. |
| 2026-01-30 | Effective date for Dallas Scrip's resignation and Damien Lamendola's appointment as President. |
Keywords
Marpai, MRAI, Executive Change, CEO, President, Corporate Governance, Leadership Transition, Damien Lamendola, Dallas Scrip, SEC Filing, 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.